# Correction to “Primary T‐cell‐based delivery platform for in vivo synthesis of engineered proteins”

PMC · DOI: 10.1002/btm2.10658 · Bioengineering & Translational Medicine · 2024-03-10

## Full-text entities

- **Genes:** Cd3e (CD3 antigen, epsilon polypeptide) [NCBI Gene 12501] {aka CD3, CD3epsilon, T3e}, Rabep2 (rabaptin, RAB GTPase binding effector protein 2) [NCBI Gene 70314] {aka 2610011A08Rik, Fra}, FOSL1 (FOS like 1, AP-1 transcription factor subunit) [NCBI Gene 8061] {aka FRA, FRA1, fra-1}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}, Nr1i3 (nuclear receptor subfamily 1, group I, member 3) [NCBI Gene 12355] {aka CAR, CAR-beta, Care2, ESTM32, MB67}, CXADRP1 (CXADR pseudogene 1) [NCBI Gene 653108] {aka CAR, CXADRP}
- **Diseases:** A2780cis tumor (MESH:D009369)
- **Chemicals:** d-Luciferin (MESH:C532924), PBS (MESH:D007854), Luc2 (-)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** A2780cis — Homo sapiens (Human), Ovarian endometrioid adenocarcinoma, Cancer cell line (CVCL_1942)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11256120/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11256120/full.md

---
Source: https://tomesphere.com/paper/PMC11256120